Fundraising Fox

Sierra Oncology

San Francisco, US · 6 known investors

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

BiotechHealthtechMedical Devices

Investors · 6

Capital Midwest FundMequon
Frazier Life SciencesPalo Altovia Daniel Estes · led
Longitude CapitalMenlo Park · $10M – $30M
RA CapitalBoston
Vivo CapitalPalo Alto · $10M – $50M
Oxford Finance LLCreportedAlexandria · $5M – $125M

In the news

Sierra Oncology Raises $135M Via Equity To Fund Lead Program Developmentfinance.yahoo.com · Jan 2022Sierra Oncology surges 50%, here is the catalystinvezz.com · Jan 2022Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)prnewswire.com · Jun 2021Sierra Oncology Announces Closing of $103 Million Public Offering and Changes to its Board of Directorsprnewswire.com · Nov 2019Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinibprnewswire.com · Aug 2018Buy Sierra Oncology Stock – SRRA Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

What does Sierra Oncology do?
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Who are Sierra Oncology's investors?
Sierra Oncology's investors include Capital Midwest Fund, Frazier Life Sciences, Longitude Capital, RA Capital, Vivo Capital, Oxford Finance LLC.
Where is Sierra Oncology headquartered?
Sierra Oncology is headquartered in San Francisco, US.